AliveCor

By Dave Muoio 04:18 pm November 22, 2019
There are few clinical areas more in need of innovation than heart disease. It’s the leading killer among men and women in the US, accounting for one in every four deaths by the CDC’s numbers, and yet it’s also a body of health conditions that could be substantially mitigated through a number of lifestyle and behavior changes. So of course it’s little surprise that cardiovascular health and care...
By Laura Lovett 03:37 pm October 31, 2019
Digital ECG maker AliveCor is teaming up with Chinese wearable company Huami Corporation on a new effort to combine the pair’s technology into medical-grade wearables.  The end goal is to have an ECG-enabled wearable with various heart features on the market by 2020.   "AliveCor's agreement with Huami achieves our corporate goal of delivering AliveCor's AI-driven subscription services and...
By Laura Lovett 04:25 pm October 22, 2019
Yesterday an SEC filing revealed that AliveCore, mobile ECG maker, raised $5.78 million in new funds. The filing, which was first spotted by Exits & Outcomes’ Brian Dolan, lists the company’s total offerings at $9.1 million, leaving roughly $3.4 million left on the table to be sold to potential investors. This investment grows on the $30 million it raised in 2017, which was led by the Mayo...
By Dave Muoio 03:45 pm August 19, 2019
Update: This story has been updated to include additional comments from AliveCor.  Mobile ECG maker AliveCor has ended sales of KardiaBand, its FDA-cleared ECG wristband designed for use with Apple Watches, a representative of the company confirmed to MobiHealthNews today.  The company appears to have pulled down the device’s purchase page sometime after June 12, according to cached versions of...
By Dave Muoio 01:33 pm July 25, 2019
After months of treading water, mobile ECG maker AliveCor has finally named its new CEO: Priya Abani, who up until this point led the Alexa Voice Service for Amazon. Abani’s three years at Amazon as general manager for devices and enablement saw her spearheading integration efforts to integrate voice assistant with Amazon’s various connected services, as well as leading its product, engineering,...
By Dave Muoio 08:42 am May 13, 2019
Mobile consumer ECG maker AliveCor announced today that its long-teased six-lead ECG device has been cleared by the FDA and will be available to customers in June of this year. “[The KardiaMobile 6L clearance] is a big deal for us, and it’s important for patients and physicians because they will be able to get a materially improved view into patients’ hearts,” Dr. Jacqueline Shreibati, chief...
By Dave Muoio 03:21 pm April 25, 2019
The last couple of months saw a pair of regulatory clearances from mobile ECG maker AliveCor surface on the FDA’s 510(k) premarket notification database — the first in March for something called KardiaAI, and the latter a dual-update for the company’s existing KardiaMobile and KardiaStation platforms for consumer and point-of-care use. With AliveCor keeping mum at the time, MobiHealthNews...
By Dave Muoio 01:33 pm April 15, 2019
Another recent update to the FDA’s 510(k) premarket notification database suggests that AliveCor is inching closer and closer to its next volley of smartphone-connected ECG products. According to the agency, the digital health company received clearance related to its consumer KardiaMobile platform, as well as the clinician-facing KardiaStation, on Friday. The application for the device or...
By Jonah Comstock 02:36 pm March 21, 2019
This article has been updated with a new photo and additional information from Omron. Omron has apparently finally received FDA 510(k) clearance for its Blood Pressure Monitor + EKG device, which was originally announced in January 2018 at CES. The device was created in partnership with AliveCor. This is a separate product from Omron's HeartGuide watch, which also incorporates AliveCor ECG...

Credit: AliveCor

By Leontina Postelnicu 11:57 am March 4, 2019
A&E departments in the UK should introduce AliveCor’s KardiaMobile device into standard care, researchers have said, for patients presenting with heart palpitations or feeling lightheaded, after a study found it was five times more effective than current tests used to diagnose heart rhythm problems. Although often harmless, if patients fully recover before getting to A&E, detecting the...